Charles Schwab Investment Management Inc. lifted its holdings in shares of CVS Health Co. (NYSE:CVS - Free Report) by 2.6% in the third quarter, according to its most recent filing with the SEC. The firm owned 12,208,668 shares of the pharmacy operator's stock after acquiring an additional 304,386 shares during the period. Charles Schwab Investment Management Inc. owned approximately 0.97% of CVS Health worth $767,681,000 as of its most recent filing with the SEC.
Other hedge funds and other institutional investors also recently made changes to their positions in the company. Garland Capital Management Inc. increased its position in CVS Health by 0.3% in the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator's stock valued at $3,591,000 after acquiring an additional 160 shares in the last quarter. Sound Income Strategies LLC increased its position in CVS Health by 7.2% in the 3rd quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator's stock valued at $151,000 after acquiring an additional 162 shares in the last quarter. Plimoth Trust Co. LLC increased its position in CVS Health by 0.4% in the 2nd quarter. Plimoth Trust Co. LLC now owns 46,637 shares of the pharmacy operator's stock valued at $2,754,000 after acquiring an additional 174 shares in the last quarter. Hexagon Capital Partners LLC boosted its stake in shares of CVS Health by 3.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator's stock valued at $331,000 after purchasing an additional 178 shares during the last quarter. Finally, Pallas Capital Advisors LLC boosted its stake in shares of CVS Health by 2.5% in the 2nd quarter. Pallas Capital Advisors LLC now owns 7,458 shares of the pharmacy operator's stock valued at $447,000 after purchasing an additional 183 shares during the last quarter. 80.66% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
Several brokerages have recently issued reports on CVS. Royal Bank of Canada reduced their target price on shares of CVS Health from $68.00 to $58.00 and set an "outperform" rating on the stock in a research note on Friday, November 15th. Barclays reduced their target price on shares of CVS Health from $75.00 to $71.00 and set an "overweight" rating on the stock in a research note on Thursday, November 7th. Evercore ISI raised their target price on shares of CVS Health from $62.00 to $75.00 and gave the company an "outperform" rating in a research note on Tuesday, October 8th. StockNews.com lowered shares of CVS Health from a "hold" rating to a "sell" rating in a research note on Thursday, November 14th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of CVS Health from $64.00 to $63.00 and set a "hold" rating on the stock in a research note on Friday, August 9th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and thirteen have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and a consensus price target of $72.28.
Read Our Latest Research Report on CVS
CVS Health Stock Up 1.6 %
Shares of NYSE CVS traded up $0.91 during midday trading on Friday, reaching $58.01. The company's stock had a trading volume of 10,428,506 shares, compared to its average volume of 11,356,283. The company has a current ratio of 0.80, a quick ratio of 0.59 and a debt-to-equity ratio of 0.80. CVS Health Co. has a fifty-two week low of $52.71 and a fifty-two week high of $83.25. The stock has a market capitalization of $73.00 billion, a price-to-earnings ratio of 14.72, a PEG ratio of 0.94 and a beta of 0.55. The stock has a 50 day simple moving average of $59.21 and a 200-day simple moving average of $58.59.
CVS Health (NYSE:CVS - Get Free Report) last posted its quarterly earnings data on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.08 by $0.01. The company had revenue of $95.43 billion for the quarter, compared to the consensus estimate of $92.72 billion. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The firm's revenue was up 6.3% compared to the same quarter last year. During the same period last year, the company earned $2.21 earnings per share. Equities research analysts predict that CVS Health Co. will post 5.43 earnings per share for the current year.
CVS Health Announces Dividend
The company also recently announced a quarterly dividend, which was paid on Friday, November 1st. Investors of record on Monday, October 21st were issued a dividend of $0.665 per share. The ex-dividend date of this dividend was Monday, October 21st. This represents a $2.66 dividend on an annualized basis and a yield of 4.59%. CVS Health's payout ratio is 67.51%.
CVS Health Company Profile
(
Free Report)
CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.
See Also
Before you consider CVS Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CVS Health wasn't on the list.
While CVS Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
